Mind Cure Receives Health Canada Authorization to Sell its Moonbeam Mushroom Products in Canada Post published:September 23, 2020 Post category:Press Release
COMPASS Pathways Closes $147 million IPO Post published:September 22, 2020 Post category:Press Release
Revive Therapeutics Provides Corporate Update on its Psychedelics Therapeutics Programs Post published:September 21, 2020 Post category:Press Release
PharmaDrug Inc. Closes Transaction to Acquire First Smart Shop in the Netherlands and Now Initiates Major Push to Acquire Best of Breed High Traffic Locations Post published:September 21, 2020 Post category:Press Release
Red Light Holland Grants Exclusive Access to a Prominent Canadian Production Company and Film Crew to Document the Company in the Netherlands Post published:September 21, 2020 Post category:Press Release
Mind Cure announces commencement of trading on the CSE Post published:September 21, 2020 Post category:Press Release
Mind Cure Becomes Latest Publicly-Traded Psychedelic Company Post published:September 17, 2020 Post category:Press Release
Red Light Holland’s Science and Innovation Division, Scarlette Lillie Joins Medical Psychedelics Working Group with Leading Academics; Professor David Nutt and Professor Jo Neill Post published:September 17, 2020 Post category:Press Release
Mindleap Health Implements HIPAA Compliance Standards and Appoints Former Canadian Ministry of Health Telemedicine Expert as Head of Program Management Post published:September 17, 2020 Post category:Press Release